NUPULSECV, INC.

Profile

Company Names

NUPULSECV, INC.
NUPULSE INC.

Addresses

5734 TRINITY ROAD, SUITE 101, RALEIGH, NC 27607

840 MAIN CAMPUS DRIVE, SUITE 350, RALEIGH, NC 27606

4711 NORTH FIRST AVENUE, TUCSON, AZ 85718

4711 NORTH FIRST STREET, TUCSON, AZ 85718

Phone Numbers

(917) 572-6064

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2010

State Incorporated:

DELAWARE

Total Amount Raised:

$14,732,498.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2020-03-10 
$2,100,757.00 
$19,999,999.00 
$17,899,242.00 
Equity 
3
2018-06-11 
$5,381,991.00 
$25,000,000.00 
$19,618,009.00 
Equity 
2
2014-06-04 
$6,699,750.00 
$6,699,750.00 
$0.00 
Equity 
1
2011-05-03 
$550,000.00 
$3,150,000.00 
$2,600,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DOUGLAS 
 
ALTSCHULER 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
NUPULSE INC.   |  NUPULSECV, INC.
DOUGLAS 
 
GODSHALL 
DIRECTOR
HEARTWARE INTERNATIONAL, INC.   |  NUPULSE INC.   |  VITAL THERAPIES INC   |  EYEPOINT PHARMACEUTICALS, INC.   |  SHOCKWAVE MEDICAL, INC.
VALLUVAN 
 
JEEVANANDAM 
DIRECTOR, PROMOTER
NUPULSE INC.
BRIAN 
 
NOVACK 
DIRECTOR
NUPULSE INC.   |  PARK BENCH HOLDINGS, INC.   |  BTM PRODUCTS, INC.   |  FUTURE METHOD, INC.   |  NUPULSECV, INC.
BRIAN 
 
NOVAK 
DIRECTOR
NUPULSECV, INC.
SONNA 
 
PATEL-RAMAN 
EXECUTIVE OFFICER
NUPULSECV, INC.
GREG 
 
SCOTT 
DIRECTOR
PHARMACA INTEGRATIVE PHARMACY INC   |  EBH HOLDING COMPANY, INC.   |  NUPULSECV, INC.
RICHARD 
 
SHERMAN 
DIRECTOR
ACTINIUM PHARMACEUTICALS, INC.   |  FUNCTIONAL TECHNOLOGIES CORP   |  NUPULSE INC.   |  NUPULSECV, INC.
ALEX 
 
SHLYANKEVICH 
DIRECTOR
NUPULSECV, INC.
DIRK 
 
SIMMONS 
DIRECTOR
NUPULSECV, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-03-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-10 
2018-07-03
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-11 
2018-06-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-11 
2014-08-12
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-06-04 
2014-06-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-06-04 
2011-05-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#